This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shenzhen Chipscreen Biosciences, Ltd.. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guangdong, CN (2007)
- Shenzhen, CN (2009)
Company Filing History:
Years Active: 2007-2009
Title: Innovator Spotlight: Boyu Li from Shenzhen, CN
Introduction
Boyu Li is an accomplished inventor based in Shenzhen, China, known for his significant contributions to the field of pharmaceuticals. With a focus on innovative compounds that target cancer and other proliferative diseases, he has developed a notable repertoire of patented inventions. His work exemplifies the intersection of scientific research and practical applications in medicine.
Latest Patents
Boyu Li holds two patents, both centering around benzamide derivatives with applications as histone deacetylase inhibitors (HDACIs).
1. **Benzamide Derivatives as Histone Deacetylase Inhibitors with Potent Differentiation and Anti-Proliferation Activity**: This invention involves the preparation and pharmaceutical use of novel benzamide derivatives, offering promising methods for treating cell proliferative diseases such as cancer and psoriasis.
2. **Histone Deacetylase Inhibitors of Novel Benzamide Derivatives with Potent Differentiation and Anti-Proliferation Activity**: Similar to his first patent, this invention also focuses on the preparation and application of benzamide derivatives in the same therapeutic domains, further underscoring Li's commitment to addressing critical health challenges.
Career Highlights
Boyu Li is a prominent member of Shenzhen Chipscreen Biosciences, Ltd., where he continues to leverage his expertise in drug development and innovation. His contributions have not only advanced his company's goals but have also enhanced the larger field of biomedical research.
Collaborations
Throughout his career, Boyu Li has collaborated with esteemed colleagues, including Xian-Ping Lu and Zhibin Li. These partnerships have allowed him to expand his research scope and push the boundaries of pharmaceutical innovations, resulting in impactful inventions that can improve patient outcomes.
Conclusion
Boyu Li’s work exemplifies the power of innovation in addressing complex medical issues. His patents related to benzamide derivatives illustrate a significant step forward in the development of treatments for cancer and other diseases. As he continues his endeavors at Shenzhen Chipscreen Biosciences, Li remains a vital contributor to the landscape of pharmaceutical inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile